ANOVA

Related by string. Anova * * variance ANOVA . ANOVA Science . Anna Ferm Anova *

Related by context. All words. (Click for frequent words.) 78 variance ANOVA 74 univariate 73 pairwise comparisons 73 Kruskal Wallis test 72 Pearson correlation coefficient 72 Wilcoxon rank sum 72 nonparametric 71 chi squared 71 bivariate 71 logistic regression 70 ANCOVA 70 regression analyzes 69 logistic regression model 69 unpaired t 69 logistic regression analysis 69 Bonferroni 69 categorical variables 68 multivariate analyzes 68 Univariate 68 logistic regression analyzes 68 covariate 68 multiple logistic regression 67 Multivariate analysis 67 univariate analysis 67 Bonferroni correction 67 Kruskal Wallis 67 interobserver reliability 67 multivariate Cox 66 logistic regression models 66 interrater reliability 66 covariance 66 generalized estimating 66 correlation coefficients 66 Rating Scale BPRS 66 immunohistochemical 66 Pearson correlation coefficients 66 multiple linear regression 66 convergent validity 66 logistic regressions 66 allele frequencies 66 multivariable logistic regression 65 subscale scores 65 conditional logistic regression 65 univariate analyzes 65 confidence intervals CIs 65 multivariate logistic regression 65 Likert 65 Poisson regression 65 multivariable analysis 65 bivariate analysis 65 retest reliability 64 Descriptive statistics 64 MDRD 64 histopathologic 64 multivariable Cox 64 covariance ANCOVA 64 posttest 64 Logistic regression 64 HOMA IR 64 interobserver 64 semiquantitative 64 intraobserver 64 immunostaining 63 mRNA expression 63 posttreatment 63 Cronbach alpha 63 χ 63 ADAS cog 63 generalized linear 63 factorial 63 linear regression analysis 63 subscales 63 Mantel Haenszel 63 Multivariate logistic regression 63 Genotypic 62 logit 62 Histologic 62 Brief Psychiatric 62 Univariate analysis 62 PANSS 62 binary logistic regression 62 intraclass correlation coefficients 62 p = .# [002] 62 Western blotting 62 recursive partitioning 62 NIHSS 62 thyroglobulin 62 multivariate regression 62 Alzheimer Disease Assessment 62 Kaplan Meier analysis 62 dichotomous variables 62 PCWP 62 CORE OM 62 linear regression analyzes 62 immunohistochemical staining 62 meta analytic 62 clinicopathological 62 allelic 62 NIH CPSI 61 meta regression 61 ROC curves 61 bivariate analyzes 61 histopathological 61 rs# [004] 61 Linear regression 61 Scale PANSS 61 -#.# ± [002] 61 Interrater reliability 61 Kaplan Meier survival 61 subscores 61 Child Behavior Checklist 61 covariates 61 qRT PCR 61 Montgomery Åsberg Depression 61 intima media thickness 61 EQ 5D 61 hierarchical clustering 61 genotypic 61 OGTT 60 ± SEM 60 F FDG PET 60 serum cortisol 60 Main Outcome Measures 60 HAM D 60 multivariate regression analysis 60 coronary stenosis 60 SNP rs# [002] 60 WAIS III 60 metabolite concentrations 60 Visual Analogue Scale VAS 60 subtests 60 stepwise logistic regression 60 MMSE 60 multivariate analysis 60 ^ sup #m 60 induced sputum 60 linkage disequilibrium 60 MMSE score 60 r2 = 60 Multiple logistic regression 60 Secondary efficacy endpoints 60 glomerular filtration rate 60 odds ratios ORs 60 preoperative PSA 60 immunoblotting 60 VNTR 60 immunohistochemical analysis 60 Response Evaluation Criteria 60 regression coefficient 59 premorbid 59 Neuropsychiatric Inventory NPI 59 P = .# 59 MADRS score 59 electrophysiologic 59 postintervention 59 HDRS 59 isoprostane 59 intact parathyroid hormone 59 Index CDAI 59 = -#.# 59 Multivariable 59 immunoreactivity 59 Histological 59 PERMP 59 intraclass correlation coefficient 59 randomized controlled trials RCTs 59 platelet reactivity 59 FDG-PET/CT 59 specific antigen PSA 59 YMRS 59 ± SD 59 Immunohistochemistry 59 multivariable 59 interrater 59 κ 59 Rating Scale MADRS 59 CI -#.# 59 oral glucose tolerance 59 Kaplan Meier curves 59 Negative Syndrome 59 ADAS Cog 59 WOMAC pain 59 biopsy Gleason 59 Kaplan Meier curve 59 methacholine challenge 59 immunohistochemistry IHC 59 uM 59 urine albumin 59 p = #.# [003] 59 null hypothesis 59 discriminant analysis 59 cognitive affective 59 Multivariate 59 apolipoprotein B 59 Repeatability 59 pairwise 59 FDG uptake 59 multivariable adjusted 59 cytologic 58 Meta analyzes 58 Visual Analog 58 Eq. 58 histologic 58 D dimer 58 ADCS ADL 58 estimated glomerular filtration 58 mammographic density 58 State Examination MMSE 58 Haplotype 58 aPTT 58 Kaplan Meier method 58 dopamine transporter gene 58 hemodynamic variables 58 μmol L 58 UPDRS 58 MTT assay 58 D Dimer 58 statistically significant p = 58 Ki# 58 genomewide 58 MetS 58 salivary cortisol 58 FEV ^ sub 58 multivariate 58 differentially expressed genes 58 dimensional echocardiography 58 International Prostate Symptom 58 Montgomery Asberg Depression 58 fasting insulin 58 etiologic 58 Immunohistochemical 58 Glomerular filtration rate 58 nomograms 58 Multiple linear regression 58 esophageal carcinoma 58 ß = 58 proportional hazards 58 tertiles 58 dose proportionality 58 AST ALT 58 subtest 58 PCa 58 Fig. 3b 58 endometrial thickness 58 Cytogenetic 58 Primary endpoints 58 C telopeptide 58 Logistic regression analysis 58 male Wistar rats 58 IL#B 58 heterozygotes 58 Immunohistochemical staining 58 Subgroup analysis 58 psychometric properties 58 differential gene expression 58 statistical significance p 58 TRUS 58 subthreshold 58 APACHE II 58 Scale Cognitive Subscale 57 PSA nadir 57 d dimer 57 FDG PET imaging 57 serum leptin 57 % Confidence Interval 57 dinucleotide 57 prospectively randomized 57 pharmacodynamic endpoints 57 Immunohistochemical analysis 57 fasting plasma 57 Distress Scale 57 #S rRNA 57 RRM1 57 Subscale 57 prespecified 57 SerDes transceivers 57 explanatory variables 57 airway hyperresponsiveness 57 df = 57 BMI z 57 HRCT 57 DAS# scores 57 Crohn Disease Activity 57 ^ sup 57 genotypic resistance 57 HAQ DI 57 prospectively defined 57 #S rRNA gene 57 cDNA libraries 57 HAM D# 57 subgroup analyzes 57 microsatellite markers 57 voxel 57 Psoriasis Area 57 dose dependently 57 tPSA 57 inferential statistics 57 apolipoproteins 57 cystatin C 57 Pharmacodynamic 57 lymph node metastasis 57 MADRS 57 MR spectroscopy 57 IQR 57 FACIT 57 sd = 57 TIMP 57 symptomatic VTE 57 eigenvalue 57 biochemical recurrence 57 histological subtype 57 NHANES III 57 nonsignificant 57 quantitative RT PCR 57 COMT genotype 57 gene polymorphisms 57 DAS# [002] 57 lumbar spine BMD 57 Gram stain 57 WOMAC 57 β = 57 periprocedural 57 estimated GFR 57 preoperatively 57 VKORC1 57 RFLP 57 subscore 57 fig. S1 57 urodynamic 57 lymphovascular invasion 57 Fig. 2A 57 transaminase 57 morphometric 57 TNSS 57 Symptom severity 57 HER2 expression 57 retrospective cohort 57 Likert type 57 Global Impression CGI 57 point Likert scale 57 clinico pathological 57 PCR RFLP 57 IgG antibody 57 erythrocyte sedimentation rate 57 antibody titer 57 hematological parameters 57 Depression Inventory 57 #.#/#.# mm Hg [003] 57 clinicopathological features 57 P ≤ 57 MBq 57 laterality 57 Subgroup analyzes 57 alanine aminotransferase ALT 57 prognostic significance 57 eGFR 57 glycated hemoglobin HbA1c 57 reverse transcriptase polymerase chain 56 anthropometric measurements 56 Cronbach 56 liver histology 56 ADHD Rating Scale 56 quantitative reverse transcriptase 56 serum TSH 56 mITT population 56 transthoracic echocardiography 56 Supplementary Table 56 Regression analyzes 56 leukocyte counts 56 chi ^ sup 56 mean ± SEM 56 allele frequency 56 multivariable regression 56 r = 56 hyperinsulinemic euglycemic clamp 56 Quantitative RT PCR 56 sensitivity specificity 56 μg liter 56 Y BOCS 56 serum PSA 56 hip BMD 56 linear regression 56 ^ Tc 56 achieved statistical significance 56 LDL HDL 56 creatinine ratio 56 NIHSS score 56 TIMP 1 56 nomogram 56 histopathologic findings 56 PaO 2 56 RT PCR assay 56 dyssynchrony 56 skin prick 56 dichotomized 56 serum IGF 56 PFGE 56 airway responsiveness 56 nucleotide substitutions 56 F FDG uptake 56 metabolic parameters 56 serum concentrations 56 HbA 1c 56 Kaplan Meier 56 C#BL/#J mice 56 Pharmacokinetic parameters 56 microsatellite instability 56 fructosamine 56 Score IPSS 56 -#.# ± [001] 56 SSRI SNRI 56 Wechsler Adult 56 QIDS SR 56 Secondary endpoints included 56 RT qPCR 56 PSQI 56 lactate dehydrogenase 56 predictive validity 56 miRNA expression 56 timepoints 56 μg kg 56 #S rDNA 56 Fig. 1A 56 SNP rs# [001] 56 noninferiority 56 undetectable HBV DNA 56 rs# [002] 56 interobserver agreement 56 Histopathological 56 Symptom Checklist 56 plasma cortisol 56 statistically nonsignificant 56 SUVmax 56 Figure 2C 56 #q# deletion syndrome 56 nonrandom 56 serum prostate 56 -#.# log# 56 rs# [001] 56 situ hybridization 56 Health Assessment Questionnaire 56 hemoglobin Hb 56 Histopathologic 56 transcriptomic 56 histologic findings 56 tertile 56 transabdominal 56 #F FDG PET 56 aspartate aminotransferase AST 56 linear regressions 56 rs# [003] 56 clinically meaningful improvement 56 prespecified secondary 56 FDG PET scan 56 regression coefficients 56 definite stent thrombosis 56 % CI #.#-#.# [004] 56 ultrasonographic 56 regression equations 56 chromatograms 56 Alkaline Phosphatase 56 CIN2 + 56 mol L 56 Incontinence Impact Questionnaire 56 Phenotypic 56 Fig. 2a 56 σ 56 metaanalysis 56 rCBF 56 UACR 56 pharmacokinetic parameters 56 Cockcroft Gault 56 microalbumin 55 phylogenetic analyzes 55 LOCF 55 serum CRP 55 cTnI 55 psychophysiological 55 coefficients 55 KOOS 55 chromatin immunoprecipitation 55 baseline FEV 55 variography 55 glycosylated hemoglobin HbA1c 55 = #.#-#.# 55 GSTP1 55 HADS 55 sonographically guided 55 histological 55 S nitrosylation 55 IIEF 55 Score DAS# 55 peripheral blood mononuclear 55 physiologic parameters 55 correlational 55 SCr 55 ERalpha 55 plasma pharmacokinetics 55 fractional anisotropy 55 postop 55 exploratory endpoints 55 colorectal adenoma 55 symptom severity 55 IPSS 55 cystatin 55 albumin excretion rate 55 multivariable analyzes 55 confidence interval CI 55 histopathologic examination 55 Doppler echocardiography 55 hematologic parameters 55 hepatic enzyme 55 Pharmacokinetic 55 PON1 gene 55 core needle biopsies 55 bronchoalveolar lavage 55 Scale cognitive subscale 55 preoperative 55 FDG PET 55 CFQ R 55 cortical activation 55 multivariable adjustment 55 Main Outcome Measure 55 quantitative PCR 55 plasma leptin 55 tHcy 55 Fig. 1E 55 Insulin sensitivity 55 tipranavir ritonavir 55 reaction RT PCR 55 liver biopsies 55 QTLs 55 QTcF 55 cytokeratin 55 % CI #.#-#.# [006] 55 Thrombolysis 55 Echocardiographic 55 inter rater reliability 55 calculated creatinine clearance 55 alanine aminotransferase 55 serum bilirubin 55 RARP 55 serum lipid 55 H#K#me# 55 Pharmacokinetic PK 55 striatal 55 carcinoembryonic antigen 55 F FDG 55 ertapenem 55 tumor necrosis 55 Prostate specific antigen 55 glomerular filtration 55 grade interpolation 55 subanalysis 55 apparent diffusion coefficient 55 serum ALT 55 Severity Index PASI 55 elevated ALT 55 carotid artery thickness 55 mRS 55 Mini Mental 55 serum ferritin 55 Likert scale 55 Disease Activity 55 ileal 55 homozygotes 55 indel 55 transvaginal sonography 55 Preoperatively 55 lesional 55 urinary N telopeptide 55 dosimetric 55 TNFalpha 55 carotid IMT 55 ECLS 55 microvessel density 55 premenopause 55 ADHD RS 55 femoral neck BMD 55 Doppler sonography 55 lymphadenectomy 55 cytological 55 SELENA SLEDAI 55 Solid Tumors RECIST 55 stepwise regression 55 eigenvalues 55 #F FDG PET CT 55 agarose gel electrophoresis 55 LDL particle 55 linear regression models 55 mg BID dose 55 serum estradiol 55 polysomnogram 55 serum HBV DNA 55 reliabilities 55 DAS# CRP 55 SLN biopsy 55 Correlation coefficients 55 eplerenone 55 Preoperative 55 Reynolds Risk Score 55 TIMI 55 Pain Intensity 55 mg kg dose 55 extramedullary 55 Recurrence Score 55 β1 55 depressive symptom 55 transcranial Doppler ultrasound 55 RECIST Response Evaluation Criteria 55 fig. S4 55 secondary efficacy endpoint 55 virological response 55 syndromal 55 nmol liter 55 transrectal ultrasound guided 55 statistically significant p 55 hypervariable 55 epistasis 55 Unified Parkinson Disease 55 alexithymia 55 intramuscular dose 55 monozygotic twins 55 log# copies mL 55 postoperative radiographs 55 neurophysiologic 55 transgene expression 55 μl 55 quantile 55 microg 55 quadratic 55 reverse transcription polymerase 55 eNO 55 τ 55 echocardiographic 55 parameter measurements 55 K#N 55 longitudinal cohort study 55 parasitaemia 55 Intervention Trial 54 regression analysis 54 micrometastasis 54 HGPIN 54 ELISA assay 54 chest radiographs 54 alkaline phosphatase 54 immunofluorescence microscopy 54 AUC0 54 calorimetric 54 Alanine 54 ABL1 54 lognormal 54 immunoreactive 54 ventricular myocardium 54 immunofluorescence 54 Geriatric Depression 54 mononuclear 54 Rating Scale UPDRS 54 prostate cancer PCa 54 CT urography 54 SGRQ 54 ESR1 54 exhaled nitric oxide 54 Baseline characteristics 54 electroencephalographic 54 EUS FNA 54 echo planar 54 anthropometric measures 54 quantitative trait loci 54 colocalization 54 #m Tc 54 Δ 54 breast carcinomas 54 transthoracic 54 μg ml 54 duplex ultrasonography 54 linkage disequilibrium LD 54 LVEF 54 T2 weighted 54 carotid intima media 54 Liver biopsies 54 Supplemental Figure 54 indels 54 thyroid stimulating hormone 54 p# p# 54 transcranial Doppler 54 COL#A# 54 DAS# remission 54 serum homocysteine 54 genetic loci 54 State Exam MMSE 54 Morphological 54 maternal serum 54 morphologic characteristics 54 fasting plasma glucose 54 NNRTI resistance 54 quantitative polymerase chain 54 cellularity 54 ug kg 54 SF #v# 54 mCi 54 parous 54 depressive symptomatology 54 SDS PAGE 54 Secondary endpoints include 54 serum lactate 54 IntroductionThe 54 biochemical relapse 54 PANSS Positive 54 HbA 1C 54 CHADS2 54 SDQ 54 axial length 54 pharmacokinetics PK 54 abdominal adiposity 54 spectrophotometric 54 stoichiometry 54 transrectal ultrasonography 54 â ‰ ¥ 54 aminotransferase 54 #.#ng/ml 54 myocardial viability 54 AUA Symptom Score 54 ELISPOT 54 urine cytology 54 IKDC 54 Secondary endpoints 54 fluorescence intensity 54 Rating Scale 54 intraventricular 54 homozygosity 54 autocorrelation 54 subclinical atherosclerosis 54 leukocyte count 54 PSADT 54 morphometric vertebral fractures 54 prepubertal 54 NMIBC 54 inhibin B 54 Digit Span 54 serum calcium 54 crossclamp 54 multivariate statistical 54 EBMT criteria 54 ACR Pedi 54 amino acid substitutions 54 histologic subtype 54 submucosal 54 radical prostatectomy RP 54 X ray absorption spectroscopy 54 pharmacodynamic parameters 54 eosinophil count 54 lymphocyte counts 54 IFN α 54 LV ejection fraction 54 hydroxy vitamin D 54 pretest probability 54 abnormal cytology 54 coexpression 54 RNFL thickness 54 nerve conduction velocity 54 neuropsychological assessment 54 hip resurfacing arthroplasty 54 denervation 54 TP# mutations 54 Mammographic 54 CR CRu 54 DHCA 54 Lp PLA 2 54 transient elastography 54 WOMAC scores 54 enzyme inhibition 54 rFSH 54 hepatic cirrhosis 54 transcriptional profiling 54 Fig. 1D 54 clinicopathologic 54 circular dichroism 54 HCCs 54 ELISpot 54 factorial design 54 postoperative complication 54 NT proBNP 54 stone formers 54 bronchial responsiveness 54 arterial oxygen saturation 54 subcellular localization 54 Fig. 2B 54 scintigraphic 54 Cardiorespiratory fitness 54 DRD2 54 CNS LS 54 left ventricular LV 54 corrected QT interval 54 MSLT 54 serum glucose 54 nodal dissection 54 HAMD 54 prognostic variables 54 prostate cancer CaP 54 methacholine 54 serum cotinine 54 SpCO 54 UGT#A# * 54 haematologic 54 urinary calcium 54 plasma folate 54 EGFP 54 microarray experiments 54 serum IgG 54 serum testosterone 54 pT2 54 ID2 54 β actin 54 Conflict Tactics 54 RECIST criteria 54 % CI #.#-#.# [007] 54 HbA 1c levels 54 inotropic agents 54 SAXS 54 nonfatal MI 54 TOP2A 54 ε 54 g mL 54 APOE genotype 54 perfusion MRI 54 TURBT 54 FOLPI 54 electrocardiographic 54 hsCRP 54 ρ 54 methodologic 54 ‰ ¥ 54 predictor variables 54 intima media thickness IMT 53 Phylogenetic analysis 53 immunohistochemistry 53 triiodothyronine 53 antimicrobial susceptibility 53 frameshift mutation 53 Epworth Sleepiness Scale 53 confidence interval #.#-#.# 53 subchronic 53 metaplasia 53 Depression Inventory BDI 53 cDNA microarray 53 SLNB 53 TEAEs 53 nondiagnostic 53 Neuropsychiatric Inventory 53 glycosylated hemoglobin 53 CC genotype 53 psychopathological symptoms 53 histologically 53 hypogonadal 53 gravimetric method 53 KRAS mutation 53 HBeAg negative patients 53 T1 weighted 53 rheumatoid factor 53 immunochemical 53 CHD mortality 53 nonrandomized 53 quantitative computed tomography 53 affective disorders 53 BPRS 53 intergenic 53 p = #.# [002] 53 tirofiban 53 ADRB2 53 urothelial carcinoma 53 microdose 53 Randomized trials 53 bone scintigraphy 53 irbesartan 53 serum albumin 53 enzyme immunoassay EIA 53 Edinburgh Postnatal Depression 53 ploidy 53 pulmonary arterial 53 mcg mL 53 antral 53 endonuclease 53 hemodynamic parameters 53 lateral radiographs 53 DGGE 53 Fibromyalgia Impact Questionnaire 53 BMI waist circumference 53 RQ PCR 53 LPS induced 53 randomisation 53 psychosocial variables 53 TMPRSS2 ERG 53 Mutational 53 urinary excretion 53 hepatic arterial 53 ultrastructural 53 suicide attempters 53 mean baseline A1C 53 highest tertile 53 parameter estimation 53 virologic responses 53 urodynamic parameters 53 DCE MRI 53 pressor response 53 Comorbidity 53 plain radiographs 53 composite endpoint 53 RT PCR 53 Numeric Rating Scale 53 human chorionic gonadotropin hCG 53 multicentre randomized 53 post hoc 53 plasma lipid 53 specific alkaline phosphatase 53 Young modulus 53 Physical Component 53 AFLP 53 QTc 53 Hazard Ratio HR 53 monozygotic 53 ^ sub 53 Fig. 1b 53 Fig. 3a 53 flow mediated dilation 53 MALDI TOF MS 53 Hb A1C 53 pCR 53 CR nPR 53 comparative genomic 53 amplicon 53 deoxy 53 CYP #D# 53 intestinal permeability 53 troponins 53 inhibin 53 δ 53 oncologic outcomes 53 #Gy 53 sonographic findings 53 hyperintensity 53 morphologic 53 #p# [003] 53 Figure 1A 53 neuropathological 53 QRS duration 53 deterministic jitter 53 Amino acid 53 serum creatinine 53 HepG2 cells 53 p ≤ 53 nephrectomy 53 confounder 53 glycated hemoglobin 53 MDRD equation 53 peak VO2 53 Bulk density 53 SGPT 53 euglycemic clamp 53 IL 1ß 53 chronicity 53 alkaline phosphatase ALP 53 NPRS 53 myocardial perfusion 53 flow cytometric 53 PCR assays 53 Score TOS 53 Sensitivity analyzes 53 lymphocytosis 53 Beck Anxiety Inventory 53 serum phosphorous 53 hypericin 53 baseline HbA1c 53 serum triglyceride 53 variogram 53 lispro 53 carboxypeptidase 53 n = 53 % CI #.#-#.# [001] 53 serum creatinine levels 53 PCR assay 53 #μg [001] 53 sociodemographic characteristics 53 Visual Analog Scale 53 sitosterol 53 budesonide pMDI 53 Finite element 53 Electrophysiological 53 pharmacodynamic PD 53 plasma glucose 53 FDG PET CT 53 perfusion abnormalities 53 Randomized controlled 53 ADCS CGIC 53 Fig. 1a 53 pT3 53 Confidence Intervals 53 Sprague Dawley rats 53 aminotransferase levels

Back to home page